Hypertension: reflections on risks and prognostication
- PMID: 19427490
- PMCID: PMC3719976
- DOI: 10.1016/j.mcna.2009.02.006
Hypertension: reflections on risks and prognostication
Abstract
Framingham Heart Study cardiovascular disease prospective population epidemiologic research has played an important role in the evolution of modern cohort study design and the advancement of preventive cardiology. To date no single essential factor has been identified; multiple interrelated factors are promoting increased risk for development of CHD. Elevated blood pressure has emerged as a prominent member of cardiovascular risk factors. The study's documentation of a strong link of blood pressure to development of cardiovascular events stimulated the pharmaceutical industry to develop medications for controlling blood pressure and, in turn, national campaigns to combat hypertension and its adverse vascular outlook.
Figures
Similar articles
-
Hypertension as a risk factor for cardiac events--epidemiologic results of long-term studies.J Cardiovasc Pharmacol. 1993;21 Suppl 2:S27-37. doi: 10.1097/00005344-199321002-00006. J Cardiovasc Pharmacol. 1993. PMID: 7692148 Review.
-
Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension.J Am Coll Cardiol. 1998 Feb;31(2):383-90. doi: 10.1016/s0735-1097(97)00493-2. J Am Coll Cardiol. 1998. PMID: 9462583
-
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.JAMA. 2004 Nov 17;292(19):2343-9. doi: 10.1001/jama.292.19.2343. JAMA. 2004. PMID: 15547161 Clinical Trial.
-
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design.Blood Press. 1998 May;7(3):176-83. doi: 10.1080/080370598437394. Blood Press. 1998. PMID: 9758088 Clinical Trial.
-
Left ventricular hypertrophy: how to influence an important risk factor in hypertension.J Hypertens Suppl. 1998 Jan;16(1):S53-8. J Hypertens Suppl. 1998. PMID: 9534098 Review.
Cited by
-
Exploring Multifactorial Relationships: Assessing the Correlation Between Cardiovascular Health Indicators and Metabolic Markers.Cureus. 2024 May 8;16(5):e59934. doi: 10.7759/cureus.59934. eCollection 2024 May. Cureus. 2024. PMID: 38854317 Free PMC article.
-
Predictors of Cardiovascular Morbidity Among Adult Hypertensive Patients: A Cross-Sectional Study from the Kingdom of Saudi Arabia.Patient Prefer Adherence. 2023 Jun 6;17:1361-1369. doi: 10.2147/PPA.S407546. eCollection 2023. Patient Prefer Adherence. 2023. PMID: 37303588 Free PMC article.
-
Prediction of cardiovascular events from systolic or diastolic blood pressure.J Clin Hypertens (Greenwich). 2022 Jun;24(6):760-769. doi: 10.1111/jch.14468. Epub 2022 Apr 26. J Clin Hypertens (Greenwich). 2022. PMID: 35470947 Free PMC article.
-
Effects of Ramadan fasting on blood pressure in hypertensive patients.Tunis Med. 2021 Juillet;99(7):727-733. Tunis Med. 2021. PMID: 35261004 Free PMC article.
-
Replication of European hypertension associations in a case-control study of 9,534 African Americans.PLoS One. 2021 Nov 18;16(11):e0259962. doi: 10.1371/journal.pone.0259962. eCollection 2021. PLoS One. 2021. PMID: 34793544 Free PMC article.
References
-
- Kannel WB, Dawber TR, et al. Factors of Risk in the Development of Coronary Heart Disease- Six-Year Follow-up Experience. The Framingham Study. An Intren Med. 1961;55:33–50. - PubMed
-
- Kannel WB. Framingham study insights into hypertensive risk of cardiovascular disease. Hypertens Res. 1995;18:181–196. - PubMed
-
- Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease: the Framingham Study. Am J Cardiol. 1971;27:335–345. - PubMed
-
- Kannel WB, Dawber TR, McGee DL, et al. Perspectives on systolic hypertension: the Framingham Study. Circulation. 1980;61:1179–1182. - PubMed
-
- Port S, Demer L, Jennrich R, Walter D, Garfinkel A. Systolic blood pressure and mortality. Lancet. 2000;355:175–180. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
